Suchen Sie nach Informationen zu Hauptsitz Von Ipsen Sa? Folgen Sie den Links unten, um alle Informationen zu finden, die Sie benötigen, und mehr.


Our company - Ipsen

    https://www.ipsen.com/our-company/
    Founded 1929, Ipsen has been a family-owned business for the past 90 years and is a publicly traded business. We have four global R&D hubs and four pharmaceutical development centers around the world, and we invested €428.4m in R&D in 2021 alone.

Ipsen - Innovation for patient care - Ipsen

    https://www.ipsen.com/
    In 2021, we achieved incredible growth and change as we implemented our strategy; ‘Focus. Together. For Patients & Society.’. From growing our pipeline with external innovation to researching and developing new treatments, we’re proud of our progress and excited to go further in 2022. Discover our 2021 Annual Report.

Ipsen - Wikipedia

    https://en.wikipedia.org/wiki/Ipsen
    none

Welcome to Ipsen US

    https://www.ipsen.com/us/
    Inspiring hope, improving patients' lives. We are a global biopharmaceutical leader dedicated to improving lives through innovative medicines in oncology, neuroscience, and rare disease. Get to know us Careers.

Investors - Ipsen

    https://www.ipsen.com/investors/
    6201 15th Avenue. Brooklyn, NY 11219. USA. Email: [email protected]. Toll-free number: +1 (866) 706-0509. Direct Dial: +1 (718) 921-8137. The Company’s ADR program is sponsored by Deutsche Bank. As the depository bank Deutsche Bank performs the …

Ipsen SA - Company Profile and News - Bloomberg Markets

    https://www.bloomberg.com/profile/company/IPN:FP
    Company profile page for Ipsen SA including stock price, company news, press releases, executives, board members, and contact information

Ipsen SA IPSEY Profile-Financials-Revenues-Growth-Market …

    https://www.plunkettresearch.com/company-profile/ipsen-sa/
    Ipsen SA is a France-based biopharmaceutical company that produces drugs for oncology, neurology and rare diseases. The firm also has a consumer healthcare business. Ipsen sells more than 20 medicines in over 115 countries. The oncology division includes medicines for neuroendocrine tumors, renal.....

Ipsen Pharma SA - Company Profile and News

    https://www.bloomberg.com/profile/company/4518183Z:SM
    Company profile page for Ipsen Pharma SA including stock price, company news, press releases, executives, board members, and contact information

Ipsen SA, I7G:MUN profile - FT.com

    https://markets.ft.com/data/equities/tearsheet/profile?s=I7G:MUN
    Ipsen SA is a France-based biopharmaceutical group specialized in specialty care. The Company operates globally through two segments: Specialty Care and Consumer Healthcare. In Specialty Care, the Company is focused on various therapeutic areas, including oncology, neurosciences and rare diseases. Its oncology portfolio includes Somatuline, Decapeptyl, …

Ipsen S.A. (IPN.PA) Stock Price, News, Quote & History

    https://finance.yahoo.com/quote/IPN.PA
    BOULOGNE-BILLANCOURT, France, July 06, 2022--Regulatory News: Under the liquidity agreement entrusted by IPSEN SA to NATIXIS ODDO BHF, as of June …

Wir hoffen, dass Sie über die obigen Links alle notwendigen Informationen zu Hauptsitz Von Ipsen Sa gefunden haben.